BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
Ksenija Nešić(The University of Melbourne), Harold C. Sullivan(Emory University), Nirmala Pandeya(University of Queensland), Tanya T. Kwan(Howard Hughes Medical Institute), Inger Olesen(Barwon Health), K. Nattress(Sydney South West Area Health Service), Elizabeth Lieschke(The University of Melbourne), A Green(QIMR Berghofer Medical Research Institute), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Andrew Farrell(University of Utah), Dorota M. Gertig(The University of Melbourne), Alexander Dobrovic(The University of Melbourne), Suzanne Moore(The University of Sydney), Holly E. Barker(The University of Melbourne), T. Sadkowsky(QIMR Berghofer Medical Research Institute), Pooja Patel(Fox Chase Cancer Center), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Silvia Casadei(University of Washington Medical Center), Kristy Shield‐Artin(The University of Melbourne), P. Mackenzie(Royal Hospital for Women), R. Paul Robertson(University of Washington), Gwo‐Yaw Ho(The University of Melbourne), Sián Fereday(Peter MacCallum Cancer Centre), Gayanie Ratnayake(Royal Women's Hospital), Milissa U. Jones(Uniformed Services University of the Health Sciences), M. Malt(QIMR Berghofer Medical Research Institute), Justin Bedő(The University of Melbourne), A. Mellon(Hunter New England Local Health District), Marc R. Radke(University of Washington), Amit M. Oza(Ontario Institute for Cancer Research), Jocelyn Sietsma Penington(Walter and Eliza Hall Institute of Medical Research), Annie Stenlake(The University of Sydney), Kathy Q. Cai(Fox Chase Cancer Center), Franziska Geissler(University Hospital of Basel), Elizabeth L. Kyran(The University of Melbourne), John J. Krais(Washington University in St. Louis), Rebecca Kristeleit(Guy's and St Thomas' NHS Foundation Trust), Iain A. McNeish(Imperial College London), Robert Betsch(Fox Chase Cancer Center), Yifan Wang(The University of Texas MD Anderson Cancer Center), Fan Zhang(The University of Melbourne), Lijun Xu(Harbin Medical University), J. Maidens(Royal Prince Alfred Hospital), K.R. Harrap(QIMR Berghofer Medical Research Institute), Yoke-Eng Chiew(Millennium Institute), T. Vanden Bergh(Royal Hospital for Women), Nadia Traficante(The University of Melbourne), Jillian A. Hung(Millennium Institute), Cassandra J. Vandenberg(The University of Melbourne)
Cited by 28
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k